Abbott Laboratories

Open: 109.32 Close: 108.75 Change: -0.57

Our AI found some flaws in Abbott Laboratories Company Inc.

The game is changing. There is a new strategy to evaluate Abbott Laboratories fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Abbott Laboratories are: Abbott, Laboratories, market, stock, ABT, trading, decline, …

Concept Map

Semantic Network

Stock Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products. The company operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Diagnostic segment offers laboratory systems in the.

Today's Summary

Abbott Laboratories (ABT) stock is trading at $110.87 as of 1:08 PM on Thursday, Apr 20, a decline of -$1.41, or -1.26% from the previous closing price of $112.28. Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits.

Today's News

Abbott Laboratories stock falls Wednesday, underperforms market - MarketWatch. Shares of Abbott Laboratories ABT shed 1.11% to $108.75 on what proved to be an all-around rough trading. Abbott Laboratories had a solid quarter despite the 18.5% decline in headline revenue. Device growth is enough to drive a double-digit gain in organic sales. The baseline is near $115; if crossed, the market could move much higher. Abbott Laboratories (ABT) stock is trading at $110.87 as of 1:08 PM on Thursday, Apr 20, a decline of -$1.41, or -1.26% from the previous closing price of $112.28. Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Abbott Laboratories (NYSE:ABT) has experienced a decrease in Q2 2023 EPS estimates. Despite this setback, analysts still expect Abbott Laboratories to report current full-year earnings at $4.36 per share. A number of hedge funds have been keeping an eye on Abbott Laboratories.

Stock Profile

"Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois."

Keywords

This document will help you to evaluate Abbott Laboratories without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Abbott Laboratories are: Abbott, Laboratories, market, stock, ABT, trading, decline, and the most common words in the summary are: abbott, laboratory, stock, abt, news, year, earnings, . One of the sentences in the summary was: Abbott Laboratories (ABT) stock is trading at $110.87 as of 1:08 PM on Thursday, Apr 20, a decline of -$1.41, or -1.26% from the previous closing price of $112.28. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbott #laboratory #stock #abt #news #year #earnings.